Delivery Order 36C25620D0076-36C25622N0169
- Not listed
- Boston Scientific Corporation, doing business as Boston Scientific, has been awarded a $89,730 firm fixed price purchase order from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 to provide TheraSphere Y-90 glass microspheres. The place of performance is in Marlborough, Massachusetts and the period of performance concludes on September 30, 2023. No set-aside designation was applied to this procurement. The TheraSphere Y-90 radioactive...
- Boston Scientific Corp has been awarded a delivery order valued at $661,095 for TheraSphere Y-90, a radiation treatment device, by the Department of Veterans Affairs through Veterans Integrated Service Network 22. This firm fixed-price contract, with an ultimate completion date of December 17, 2026, is being performed in Marlborough, Massachusetts, where Boston Scientific maintains its headquarters. The award was issued on December 18, 2025, and no set-aside designation was utilized in this...
- Boston Scientific Corp was awarded a firm fixed-price delivery order valued at $328,110 for TheraSphere Y-90 nuclear medicine products under the VA Prosthetic Implants and Appliances 2016-2021 master contract. The delivery order, issued on October 1, 2023, with an ultimate completion date of September 30, 2024, supports the Department of Veterans Affairs through Veterans Integrated Service Network 10. Performance will occur at Boston Scientific's facility in Marlborough, Massachusetts. This...
- Boston Scientific Corporation, doing business as Boston Scientific, was awarded a $89,975 firm fixed price purchase order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22. The award is for the delivery of TheraSphere Y-90 radioactive microspheres to support interventional radiology treatment services through September 2023. No set aside designation was indicated. Boston Scientific holds an existing indefinite delivery contract with the...
- Boston Scientific Corp has been awarded a delivery order valued at $4.06M for TheraSphere Yttrium-90 Glass, a specialized radiation treatment device, by Veterans Integrated Service Network 6 (VISN 6), a civilian healthcare network within the Department of Veterans Affairs. The contract, awarded on April 1, 2024, operates under a firm fixed-price delivery order structure with an ultimate completion date of December 31, 2028. The award carries no set-aside designation, indicating Boston Scientific...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 6 awarded a $171,000 purchase order to Boston Scientific Corporation for the delivery of Y-90 Theraspheres. As the prime contractor, Boston Scientific will provide radioactive microspheres used in interventional radiology procedures to treat cancer in the liver. The single award firm fixed price contract has a base period of performance from September 2023 through February 2024 for the medical...
- This is a firm fixed-price purchase order awarded by the Veterans Integrated Service Network 22 (VISN 22) of the U.S. Department of Veterans Affairs (VA) to Boston Scientific Corp, a leading manufacturer of medical devices. The contract, valued at $88,750.00, is for the supply of Y-90 TheraSphere radioactive microspheres used in interventional radiology treatments. This award is not a set-aside contract. Boston Scientific has received multiple delivery orders and indefinite delivery/indefinite...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 22 (VISN 22), awarded a $397,000 firm fixed-price delivery order to Boston Scientific Corp for TheraSphere Y-90, a yttrium-90 glass radiation treatment device used in interventional oncology procedures. The contract, awarded on October 1, 2025, with a completion date of September 30, 2026, represents a non-set-aside competitive award to the Marlborough, Massachusetts-based medical device manufacturer. Boston...
- The U.S. Department of Veterans Affairs (VA) awarded a $392,825 firm fixed-price delivery order contract to Boston Scientific Corp, doing business as Boston Scientific, for Y-90 TheraSphere radioactive microspheres. This contract is not a set-aside and has an ultimate completion date of October 31, 2025. Boston Scientific is a leading manufacturer of medical devices that provides a wide range of minimally invasive solutions to federal agencies. This award is likely part of a larger indefinite...
- The Department of Veterans Affairs (VA) awarded a $121,250 firm fixed price purchase order to Boston Scientific Corp for TheraSphere Y-90 cancer treatment, including the TheraSphere radioactive microspheres, administration kits, and administration sets. This order was placed through the VA's Greater Los Angeles Healthcare System to support radioembolization procedures for non-operable liver cancer patients. The purchase order has a one-year period of performance and does not include a...
- 36C25620D0076Indefinite Delivery Contract
- 36C25620D0076-36C25622N0169Delivery Order
Boston Scientific Corporation, doing business as Boston Scientific, was awarded a $313,200 firm fixed price delivery order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16 to provide Yttrium-90 TheraSphere radioactive microspheres. This delivery order was issued against the company's existing indefinite delivery contract with the VA worth up to $295 million over five years to supply surgical implants and related services. No set-aside designation was specified for this award. TheraSphere is a treatment for inoperable liver cancer involving the targeted delivery of radioactive microspheres to the tumor site. This delivery order will allow Boston Scientific to provide interventional radiology services through September 2022 in support of the VA's cancer care programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Funding Only Action | ($67k) | 2/13/24 | |
| Not listed | Not listed | $380.6k | 10/1/21 |